Taken together, our study revealed that RBMS1 is a promising anti‐metastasis target and the RBMS1 inhibitor NTP is a potent therapeutic agent for anti‐metastasis therapy in human lung cancer. The gene discussed is RBMS1; the disease is lung carcinoma.